PCSK9 and Alzheimer disease: Therefore, in addition to affecting LDL-C levels, PCSK9 has several other functions, and its inhibition offers a novel therapeutic avenue for extrahepatic organ diseases, such as acute myocardial infarction (AMI) and AD (Abuelezz and Hendawy, 2021).